A randomized, double-blind, placebo-controlled study of the safety and tolerability of Study Drug and its effects on biomarkers in subjects with coronary artery disease.
Explore related content and topics
Case Study
Achieving Challenging Recruitment Goals and Timelines in a Pediatric Type 2 Diabetes Study
Recruiting pediatric patients for type 2 diabetes mellitus (T2DM) studies is extremely challenging. Patients are difficult to identify and often face…
View Resource
Blog
Ask the Experts: Insights on NASH and the Current Research and Treatments
NASH (Non-Alcoholic Steatohepatitis) is a rising disease that is sweeping the population. It is a terminal diagnosis that currently requires a liver…
Read Story
Newsletter
Industry Watch
This week’s Industry Watch is covering better understanding of disease, from the relationship between COVID-19 and the gut - to the intersection of…
Read More
View all related content and resources for Cardio-Metabolic
Explore Insights